The data, unveiled today and to be included in the ObesityWeek® 2025 press conference on November 5th, were among seven ...

The MarketWatch News Department was not involved in the creation of this content. Program ensures continued access to treatment for patients enrolled in the Federal Employee & Retirees Health Plan ...

Data to be shared during an ObesityWeek press conference includes four of seven data presentations supporting CONTRAVE and its utility in helping people lose weight BRENTWOOD, Tenn., Oct. 28, 2025 ...

The approval of this second site enhances production capacity, confirming continued patient access to CONTRAVE while reinforcing the company's broader commitment to obesity research and treatment.

U.S-based Eli Lilly (LLY) and Denmark's Novo Nordisk (NVO) — will be sold implementing MFN realities to Medicare patients at dramatically reduced prices. Eli Lilly (Zepbound, Mounjaro) and Novo ...

Contrave, the weight loss pill that combats food cravings, has launched its first-ever TV commercial-- with audio that features new lyrics to Lesley Gore’s 62-year-old feminist anthem “You Don’t Own ...

Program ensures continued access to treatment for patients enrolled in the Federal Employee & Retirees Health Plan (FEP) BRENTWOOD, Tenn., Oct. 23, 2025 /PRNewswire/ -- Currax Pharmaceuticals LLC, a ...

The MarketWatch News Department was not involved in the creation of this content. Data to be shared during an ObesityWeek press conference includes four of seven data presentations supporting CONTRAVE ...

BRENTWOOD, Tenn., March 20, 2025 /PRNewswire/ -- Currax Pharmaceuticals LLC ("Currax"), a specialty pharmaceutical company and manufacturer of the #1 branded oral weight loss medication CONTRAVE ® ...